Firebrick Pharma Limited (FRE.AX)

AUD 0.07

(0.0%)

Operating Expenses Summary of Firebrick Pharma Limited

Firebrick Pharma Limited's latest annual operating expenses in 2024 was -22.78 Thousand AUD , down -46.65% from previous year.
Firebrick Pharma Limited's latest quarterly operating expenses in 2024 FY was 3.07 Million AUD , down -55.2% from previous quarter.
Firebrick Pharma Limited reported a annual operating expenses of 6.85 Million AUD in annual operating expenses 2023, up 40.56% from previous year.
Firebrick Pharma Limited reported a annual operating expenses of 4.87 Million AUD in annual operating expenses 2022, up 70.44% from previous year.
Firebrick Pharma Limited reported a quarterly operating expenses of 521.41 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.
Firebrick Pharma Limited reported a quarterly operating expenses of 1.36 Million AUD for 2024 Q1, down -63.03% from previous quarter.

Annual Operating Expenses Chart of Firebrick Pharma Limited (2024 - 2019)

Historical Annual Operating Expenses of Firebrick Pharma Limited (2024 - 2019)

Year	Operating Expenses	Operating Expenses Growth
2024	-22.78 Thousand AUD	-46.65%
2023	6.85 Million AUD	40.56%
2022	4.87 Million AUD	70.44%
2021	2.86 Million AUD	42.52%
2020	2 Million AUD	71.17%
2019	1.17 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 FY	3.07 Million AUD	-55.2%
2024 Q4	521.41 Thousand AUD	0.0%
2024 Q1	1.36 Million AUD	-63.03%
2024 Q2	907.07 Thousand AUD	-33.47%
2024 Q3	521.41 Thousand AUD	-42.52%
2023 Q1	1.58 Million AUD	-29.47%
2023 FY	6.85 Million AUD	40.56%
2023 Q4	3.68 Million AUD	99.74%
2023 Q3	1.84 Million AUD	-41.3%
2023 Q2	3.14 Million AUD	98.33%
2022 Q4	2.24 Million AUD	34.79%
2022 FY	4.87 Million AUD	70.44%
2022 Q3	1.66 Million AUD	29.5%
2022 Q2	1.28 Million AUD	67.23%
2022 Q1	770.23 Thousand AUD	-59.07%
2021 Q1	489.93 Thousand AUD	0.0%
2021 FY	2.86 Million AUD	42.52%
2021 Q4	1.88 Million AUD	100.0%
2021 Q3	940.96 Thousand AUD	-1.03%
2021 Q2	950.71 Thousand AUD	94.05%
2020 FY	2 Million AUD	71.17%
2019 FY	1.17 Million AUD	0.0%

Peer Operating Expenses Comparison of Firebrick Pharma Limited

Name	Operating Expenses	Operating Expenses Difference
Mayne Pharma Group Limited	264.63 Million AUD	100.009%